Video index

1. Call to order, logistical announcements, and roll call

2. Consideration of draft meeting minutes for April 22, 2026, meeting

3. Board consideration and approval of the TPI Business Plan, due no later than June 1, 2026, pursuant to Texas Government Code, Section 2177.006, including TPI staff updates and recommendations

4. Texas Pharmaceutical Initiative Advisory Council (TPIAC) members and other covered agency representatives have been invited to advise and engage in discussions with the TPI Board on matters and activities (see Texas Government Code, Section 2177.008, in general): a. Pertaining to the implementation of the TPI Business Plan; b. Updates on member and covered agencies’ activities pertinent to procurement and/or management of pharmaceuticals; and c. On carrying out the duties imposed on the TPI Board

5. Discussion of external stakeholders’ input received by TPI Staff via questionnaire responses regarding the implementation of the TPI Business Plan

Items 6 & 7

8. Public comment

9. Review of action items from the current meeting, discussion of agenda items for future meetings, pending informational requests or action items from prior meetings, and important dates

May 20, 2026 Texas Pharmaceutical Initiative Board

Full agenda
Share this video

1. Call to order, logistical announcements, and roll call

2. Consideration of draft meeting minutes for April 22, 2026, meeting

3. Board consideration and approval of the TPI Business Plan, due no later than June 1, 2026, pursuant to Texas Government Code, Section 2177.006, including TPI staff updates and recommendations

4. Texas Pharmaceutical Initiative Advisory Council (TPIAC) members and other covered agency representatives have been invited to advise and engage in discussions with the TPI Board on matters and activities (see Texas Government Code, Section 2177.008, in general): a. Pertaining to the implementation of the TPI Business Plan; b. Updates on member and covered agencies’ activities pertinent to procurement and/or management of pharmaceuticals; and c. On carrying out the duties imposed on the TPI Board

5. Discussion of external stakeholders’ input received by TPI Staff via questionnaire responses regarding the implementation of the TPI Business Plan

Items 6 & 7

8. Public comment

9. Review of action items from the current meeting, discussion of agenda items for future meetings, pending informational requests or action items from prior meetings, and important dates

© 2003-2026 Swagit Productions, LLC